NL-OMON49786已完成不适用
Multi-centre EuRopean study of MAjor Infectious Disease Syndromes (MERMAIDS) * Acute Respiratory Infections (MERMAIDS ARI) 2.0 - MERMAIDS-ARI 2.0
niversitair Medisch Centrum Utrecht0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •Patient is admitted to hospital and fulfills selection criteria A or B and
- •should be able to be enrolled in the study within 48 hours after fulfilling the
- •eligibility criteria :
- •A. Patients of all ages with respiratory symptoms as reason for admission Upon
- •admission, all of the following:
- •1. Clinical suspicion of a new episode of acute respiratory tract infection
- •with a high probability of COVID19 diagnosis (eg. based on epidemiological
- •linkage or diagnostic procedures ).
- •2. Primary reason for hospital admission is clinical suspicion of a new episode
- •3. Onset of the following symptoms within the time window of last 14days: i.
- •Sudden onset of self-reported fever OR temperature of * 38°C at presentation
- •AND ii. At least one respiratory symptom (cough, sore throat, runny or
- •congested nose, dyspnea) AND iii. At least one systemic symptom (headache,
- •muscle ache, sweats or chills or tiredness).
- •B. Patients without respiratory symptoms as reason for admission, one of the
- •1. Patients of all ages who have a Laboratory confirmed SARS-CoV-2 infection at
- •the time of eligibility check. Microbiological diagnosis should be confirmed by
- •molecular testing. If additional tests such as antigen detection are validated
- •and available at the time of inclusion, it should be confirmed by a reference
- •This allows for additional identification of 1) severe COVID-19 cases
- •presenting to care but without fever, and 2) nosocomial cases of COVID-19
- •2. In In patients <18 years of age only:
- •Positive serology (and/or PCR-test) for SARS-CoV-2 AND Clinical suspicion of
- •Paediatric Inflammatory Multi-system Syndrome * temporally associated with
- •SARS-CoV 2 (PIMS-TS):
- •https://picsociety.uk/wp-content/uploads/2020/05/PIMS-TS-Critical-Care-Clinical-
- •Guidance-v4.pdf
排除标准
- •1.Inability to obtain consent from patient or representative
- •2.Patient transferred from another hospital ,being hospitalized for over 48
- •hours in total (applicable to patients with respiratory symptoms as reason for
- •admission) ,
- •Participation in an interventional study or other observational study will not
- •be considered an exclusion criteria
研究者
相似试验
招募中
不适用
Multi-centre EuRopean study of MAjor Infectious Disease Syndromes (MERMAIDS) - Acute Respiratory InfectionsfluRespiratory infection1001981510024970NL-OMON50667niversity of Oxford, contact prof. Peter Horby280
已完成
不适用
Multi-centre European study of major infectious disease syndromes (MERMAIDS) – Acute respiratory infectionsISRCTN18034878niversity of Oxford (UK)2,000
招募中
不适用
Multi-centre European study of major infectious disease syndromes - Arboviral compatible febrile illnessArboviral compatible febrile illnessInfections and InfestationsISRCTN74074706niversity of Oxford1,500
已完成
不适用
Community-acquired sepsis-like syndrome and paediatric acute respiratory tract infection in childhood studyISRCTN66872125Fondazione PENTA Onlus1,000
尚未招募
不适用
Multi-centre EuRopean study of Major Infectious Disease Syndromesepidemicsinfectious diseases10047438NL-OMON43251Fondazione PENTA onlus27